Forbes September 3, 2024
Joshua P. Cohen

Enabling patients to order prescription medications directly from the drug maker is an emerging trend exemplified by the launch this year of two online platforms, LillyDirect and PfizerForAll, by Eli Lilly and Pfizer, respectively. Other pharmaceutical companies may follow suit. While these initiatives facilitate patient access to certain products, they also raise (ethical) questions concerning the possible disruption of established patient-physician relationships and the potential for conflicts of interest.

The drug maker Eli Lilly launched a site called LillyDirect in January that allows patients with diabetes, obesity and migraine to connect to telehealth providers and in-person referrals who can prescribe medications, which are then filled by third-party pharmacy dispensing services, such as Truepill or Amazon Pharmacy, and in the case...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards
The Evolving Role of Pharmacists in Custom Pathway Implementation
Pharma Pulse 11/25/24: Deepening Patient Relationships,

Share This Article